Cape Coral, FL

C&A Clinical Trials Corp

Infections

Eye Diseases

Thyroid Diseases

Respiratory Syncytial Virus Infections

Graves Ophthalmopathy

EDP-938

VRDN-003

Enanta Pharmaceuticals

Viridian Therapeutics

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, VRDN-003, in participants with active Thyroid Eye Disease (TED).

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

C&A Clinical Trials Corp | Cape Coral, FL

Site insights

Work at this site?

Active trials

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED) (REVEAL-1)

Trial sponsors